logo-loader
ASX:RCE OTC:RECEF

Recce Pharmaceuticals Ltd

Receive alerts
Market:
ASX
Price
0.44 AUD
Day Change
2.33%
Market Cap:
$89.63 m
52 weeks high
0.78
52 weeks low
0.41

In brief

Recce Pharmaceuticals Ltd (ASX:RCE) is developing a new class of synthetic anti-infectives designed to address the urgent global health threat of antibiotic-resistant superbugs.

Snapshot

  • Recce Pharmaceuticals gaining financial leverage and progressing clinical trials, says Edison Investment Research
  • The smart money in medicine: the silent pandemic
  • Recce Pharmaceuticals’ valuation lifted by Edison Investment Research following progress on RECCE 327
  • Recce Pharmaceuticals hits major milestone in R327 clinical trial for UTI/urosepsis